Skip to content
OpenCapital
Get started

Lyell Immunopharma, Inc. LYEL Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$15.0K
EPS-$2.13Beat by $0.68
EPS estimate-$2.81

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$4.6K
EPS estimate-$2.02

Versus estimates

Revenue

Q1 2026$2.0KMiss by $1.0KQ4 2025$6.0KMiss by $9.3K
Q3 2025$15.0K
Q2 2025$8.0KBeat by $4.0KQ1 2025$7.0KQ4 2024$11.0K

Diluted EPS

Q1 2026-$1.10Beat by $1.68Q4 2025-$7.68Miss by $5.53
Q3 2025-$2.13Beat by $0.68
Q2 2025-$2.89Beat by $0.91Q1 2025-$3.60Beat by $0.20Q4 2024-$0.72Miss by $0.54

Ask the moment Lyell Immunopharma, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lyell Immunopharma, Inc. report Q3 2025 earnings?
Lyell Immunopharma, Inc. (LYEL) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Lyell Immunopharma, Inc.'s Q3 2025 revenue and EPS?
Lyell Immunopharma, Inc. reported revenue of $15.0K and eps of $-2.13 for Q3 2025.
Did Lyell Immunopharma, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-2.81 by $0.68.
How did Lyell Immunopharma, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 55.9% from $34.0K a year earlier and eps declined 1152.9% from $-0.17.
Where can I find Lyell Immunopharma, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-273269) and the 10-Q periodic report (0001628280-25-051619) directly on SEC EDGAR. The filing index links above go to sec.gov.